Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Haley McCracken"'
Autor:
Jeanna Wallenta Law, Debanjali Mitra, Henry G. Kaplan, Tamuno Alfred, Adam M. Brufsky, Birol Emir, Haley McCracken, Xianchen Liu, Ronda G. Broome, Chenan Zhang, Caroline DiCristo, Connie Chen
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 1047-1061 (2022)
This retrospective single-arm study assessed real-world treatment patterns and clinical outcomes in patients with hormone receptor—positive/human epidermal growth factor receptor 2—negative (HR+/HER2−) advanced/metastatic breast cancer (A/MBC)
Externí odkaz:
https://doaj.org/article/f8c89b12620c474d8fca86acf4db753d
Autor:
Jill M. Johnsen, Shelley N. Fletcher, Angela Dove, Haley McCracken, Beth K. Martin, Martin Kircher, Neil C. Josephson, Jay Shendure, Sarah E. Ruuska, Leonard A. Valentino, Glenn F. Pierce, Crystal Watson, Dunlei Cheng, Michael Recht, Barbara A. Konkle
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:2022-2034
Hemophilia A (HA) and hemophilia B (HB) are rare inherited bleeding disorders. Although causative genetic variants are clinically relevant, in 2012 only 20% of US patients had been genotyped.My Life, Our Future (MLOF) was a multisector cross-sectiona
Autor:
Jeanna Wallenta Law, Zartash Gul, Anna Berry, Michael A. Thompson, Christopher Willner, Sowjanya Vuyyala, Haley McCracken, Katherine Geverd, Frank M. Wolf, Thomas D. Brown, Philip Kuriakose
Publikováno v:
Cancer Research. 82:6259-6259
Background and Objective: Molecular testing and targeted treatments for patients (pts) diagnosed with AML have evolved in recent years. Real-world testing patterns, including next-generation sequencing (NGS), and clinical management of pts with AML w
Autor:
Zartash Gul, Jeanna Wallenta Law, Philip Kuriakose, Michael A. Thompson, Haley McCracken, Sowjanya Vuyyala, Anna B. Berry, Francesca Coutinho, Christopher Willner, Thomas D. Brown, Katherine Geverd, Frank M. Wolf
Publikováno v:
Blood. 138:4443-4443
Background and Objective: Molecular testing and treatment patterns for patients (pts) diagnosed with acute myelogenous leukemia (AML) have evolved over recent years. Next-generation sequencing (NGS) technologies allow for detection of somatic gene al
Autor:
Crystal Watson, Barbara A. Konkle, Michael Recht, Jay Shendure, Neil C. Josephson, Glenn F. Pierce, Angela Dove, Beth Martin, Leonard A. Valentino, Martin Kircher, Sarah Ruuska, Jill M. Johnsen, Haley McCracken, Shelley N Fletcher, Dunlei Cheng
Publikováno v:
Blood. 136:19-19
Background Hemophilia A (HA) and hemophilia B (HB) are rare X-linked bleeding disorders. Hemophilia genotype is important to inform reproductive planning, pregnancy, neonatal management, inhibitor risk, disease severity, and understanding of disease